Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients?

In solid organ transplant recipients, cancer is associated with worse prognosis than in the general population. Among the causes of increased cancer‐associated mortality, are the limitations in selecting the optimal anticancer regimen in solid organ transplant recipients, because of the associated r...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggiore, Umberto, Palmisano, Alessandra, Buti, Sebastiano, Claire Giudice, Giulia, Cattaneo, Dario, Giuliani, Nicola, Fiaccadori, Enrico, Gandolfini, Ilaria, Cravedi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews in Clinical Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298293/
https://www.ncbi.nlm.nih.gov/pubmed/34555228
http://dx.doi.org/10.1111/tri.14115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298293/
https://www.ncbi.nlm.nih.gov/pubmed/34555228
http://dx.doi.org/10.1111/tri.14115

Ejemplares similares